Helen Tudball

Mr. Kandel has extensive experience leading leveraged, special situations and acquisition finance and restructuring matters under English and U.S. law, and is considered one of the leading acquisition finance lawyers in London.Significantly, he brings to bear an unusually broad depth of experience beyond his core focus area, having had experience over the years in high-yield and debt capital markets, mergers and acquisitions, securitization, derivatives, margin loans, fund finance, investment...

Patrick Doris is a partner in Gibson Dunn’s Dispute Resolution Group in London, where he specialises in global white-collar investigations, commercial litigation and complex compliance advisory matters. Mr. Doris’ practice covers a wide range of disputes, including white-collar crime, internal and regulatory investigations, transnational litigation, class actions, contentious antitrust matters and administrative law challenges against governmental decision-making. Mr. Doris handle...

Raminta Dereskeviciute focuses her practice on product compliance, trade regulation (sanctions and export controls) and ESG. She has significant experience in advising on EU and UK chemical legislation (REACH), product safety and liability rules and frequently represents clients before the European Chemicals Agency Board of Appeal. Raminta also advises businesses on the implications Brexit has in relation to a range of regulatory compliance issues. Raminta counsels clients on the EU and the U...

James Fisher is a partner in the Finance Group in Alston & Bird’s London office, focusing on debt capital markets, structured finance, securitisation, and derivatives transactions, with a particular specialty in advising corporate trust, agency, and issuer clients across a broad spectrum of cross-border and domestic financings.

Gary Born is the chair of the International Arbitration Practice Group. Mr. Born is widely regarded as the world's preeminent authority on international commercial arbitration and international litigation. He has been ranked for more than 20 years as one of the world's leading international arbitration advocates and the leading arbitration practitioner in London.

Ali Nikpay is a top attorney recognized by Best Lawyers in the practice area(s) of Competition Law. Ali, who practices law in London, United Kingdom, has been recognized since 2025. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Ali is held by other top lawyers in the same geographic and legal practice area.

Deborah Ruff leads Pillsbury’s Arbitration - U.S. & International practice. She has extensive experience in multi-jurisdiction disputes, with a focus on high-value and complex international arbitration in the energy, infrastructure and construction, telecommunications and financial sectors. Deborah conducts international arbitration disputes often over JOAs, the construction of and off-take from refineries and petrochemical plants, as well as rig, energy trading and transport, and c...

Simon Cook has experience in a wide variety of banking and finance transactions, including in particular in relation to structured trade finance, trade finance, project finance, invoice discounting facilities and borrowing-base facilities in Africa, the Middle East, Asia and the CIS. His work in the structured trade area covers a range of pre-export and prepayment financings acting for both lenders and borrowers notably in oil, telecoms, soft commodities and metals sectors with particular exp...

Greg Norman is a top attorney recognized by Best Lawyers in the practice area(s) of Private Equity Law. Greg, who practices law in London, United Kingdom, has been recognized since 2024. This recognition is based on an exhaustive peer-review survey, reflecting the high esteem in which Greg is held by other top lawyers in the same geographic and legal practice area.

Tim is a partner in Goodwin’s Technology and Life Sciences groups, based in the Cambridge and London offices.Mr. Worden regularly advises life sciences companies on licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad spectrum of regulatory matters. His expertise also includes advising on the IP and regulatory aspects of M&A transactions, IPOs and venture capital investments. Outside of the life sciences sector, Mr. Wor...